Miyashita Katsuyoshi, Hayashi Yutaka, Fujisawa Hironori, Hasegawa Mitsuhiro, Yamashita Junkoh
Department of Neurosurgery, Kanazawa University Hospital, Kanazawa, Japan.
J Neurosurg. 2004 Dec;101(6):1045-8. doi: 10.3171/jns.2004.101.6.1045.
Solitary fibrous tumor (SFT) is a benign and rare neoplasm. To date, only 37 patients with intracranial SFTs have been reported. Although a number of the tumors were recurrent and some later underwent malignant transformation, none of these lesions progressed to cerebrospinal fluid (CSF) dissemination. In this paper the authors report a case of SFT in which the lesion recurred several times and ultimately was disseminated by the CSF. The patient was a 63-year-old woman with multiple intracranial and spinal tumors. Fifteen years before this presentation, at the age of 48 she had been hospitalized for resection of a falcotentorial tumor. During the ensuing 15 years she underwent multiple surgeries and sessions of radiation therapy for recurrent lesions. The exclusive location of her tumors in the subarachnoid space at the end of this 15-year period indicate CSF dissemination of the tumor. The tumor that was resected when the patient was 48 years old and the latest resected lesion were analyzed by performing immunohistological CD34, epithelial membrane antigen, vimentin, S100 protein, and reticulin staining, and determining the MIB-1 labeling index (LI). Most of the results were identical, and both tumors were diagnosed as SFT according to a staining pattern that showed a strong and diffuse positive reaction for CD34. Nevertheless, the authors noted that the MIB-1 LI increased from less than 1% in the original tumor to 13% in the latest tumor. The increased proliferation of MIB-1 indicates that the malignant transformation could have occurred during tumor recurrence with CSF dissemination.
孤立性纤维瘤(SFT)是一种良性罕见肿瘤。迄今为止,仅报道过37例颅内SFT患者。尽管一些肿瘤复发,部分后来发生恶变,但这些病变均未进展至脑脊液(CSF)播散。本文作者报告1例SFT病例,该病变多次复发,最终通过CSF播散。患者为一名63岁女性,患有多发颅内和脊柱肿瘤。此次就诊前15年,48岁时她因切除小脑幕肿瘤住院。在随后的15年里,她因复发病变接受了多次手术和放疗。在这15年结束时,其肿瘤仅位于蛛网膜下腔,提示肿瘤通过CSF播散。对患者48岁时切除的肿瘤和最新切除的病变进行免疫组织化学CD34、上皮膜抗原、波形蛋白、S100蛋白和网硬蛋白染色,并测定MIB-1标记指数(LI)。大多数结果相同,根据CD34呈强弥漫性阳性反应的染色模式,两个肿瘤均诊断为SFT。然而,作者指出,MIB-1 LI从原发肿瘤的不到1%增加到最新肿瘤的13%。MIB-1增殖增加表明在肿瘤复发伴CSF播散过程中可能发生了恶变。